Bioinformatics and cheminformatics approaches to identify pathways, molecular mechanisms and drug substances related to genetic basis of cervical cancer

References

• Akash, S., Kumer, A., Chandro, A., Chakma, U., & Matin, M. M. (2023). Quantum calculation, docking, ADMET and molecular dynamics of ketal and non-ketal forms of d-glucofuranose against bacteria, black & white fungus, and triple-negative breast cancer. Bioint. Res. Appl. Chem., 13, 374.
   Google Scholar
• An, X., Xu, F., Luo, R., Zheng, Q., bin Lu, J., Yang, Y., Qin, T., Yuan, Z., Shi, Y., Jiang, W., & Wang, S. (2018). The prognostic significance of topoisomerase ii alpha protein in early stage luminal breast cancer. BMC Cancer, 18, 331. https://doi.org/10.1186/s12885-018-4170-7
   PubMed Web of Science ®Google Scholar
• Banerjee, P., Eckert, A., Schrey, A. K., & Preissner, R. (2018). Protox-ii: A webserver for the prediction of toxicity of chemicals. Nucleic Acids Research, 46(W1), W257-63.
   Web of Science ®Google Scholar
• Banuelos˜-Villegas, E. G., Perez’-yPerez, M. F., & Alvarez-Salas, L. M. (2021). Cervical cancer, papillomavirus, and miRNA dysfunction. Frontiers in Molecular Biosciences, 8, 758337. https://doi.org/10.3389/fmolb.2021.758337
   PubMed Web of Science ®Google Scholar
• Benjamini, Y., & Yekutieli, D. (2001). The control of the false discovery rate in multiple testing under dependency. The Annals of Statistics, 29(4), 1165–1188. https://doi.org/10.1214/aos/1013699998
   Web of Science ®Google Scholar
• Berman, H. M., Battistuz, T., Bhat, T. N., Bluhm, W. F., Bourne, P. E., Burkhardt, K., Feng, Z., Gilliland, G. L., Iype, L., Jain, S., Fagan, P., Marvin, J., Padilla, D., Ravichandran, V., Schneider, B., Thanki, N., Weissig, H., Westbrook, J. D., & Zardecki, C. (2002). The protein data bank. Acta Crystallographica Section D, Biological Crystallography, 58(Pt 6 No 1), 899–907. https://doi.org/10.1107/s0907444902003451
   PubMedGoogle Scholar
• Bhatla, N., Aoki, D., Sharma, D. N., & Sankaranarayanan, R. (2021). Cancer of the cervix uteri: 2021 update. International Journal of Gynecology & Obstetrics, 155, 28–44.
   PubMed Web of Science ®Google Scholar
• Branca, M., Ciotti, M., Giorgi, C., Santini, D., Bonito, L. D., Costa, S., Benedetto, A., Bonifacio, D., Bonito, P. D., Paba, P., Accardi, L., Syrjanen, S. M., Favalli, C., & Syrjanen, K. J. (2007). Up-regulation of proliferating cell nuclear antigen (pcna) is closely associated with high-risk human papillomavirus (HPV) and progression of cervical intraepithelial neoplasia (cin), but does not predict disease outcome in cervical cancer. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 130(2), 223–231.
   PubMed Web of Science ®Google Scholar
• Canfell, K., Kim, J. J., Brisson, M., Keane, A., Simms, K. T., Caruana, M., Burger, E. A., Martin, D., Nguyen, D. T., Benard’, E., et al. (2020). Mortality impact of achieving who cervical cancer elimination targets: A comparative modelling analysis in 78 low-income and lower-middle-income countries. The Lancet, 395(10224), 591–603.
   PubMed Web of Science ®Google Scholar
• Caplan, M. (2014). Transcription factors. Reference module in biomedical sciences. Elsevier. https://www.sciencedirect.com/science/article/pii/B9780128012383054660
   Google Scholar
• Casey, D., Demko, S., Sinha, A. K., Mishra-Kalyani, P. S., Shen, Y. L., Khasar, S. G., Goheer, M. A., Helms, W. S., Pan, L., Xu, Y., Fan, J., Leong, R., Liu, J., Yang, Y., Windsor, K., Ou, M.-Y., Stephens, O., Oh, B., Reaman, G., … Singh, H. (2021). Fda approval summary: Selumetinib for plexiform neurofibroma. Clinical Cancer Research, 27, 4142–4146.
   PubMed Web of Science ®Google Scholar
• Causin, R. L., Freitas, A. J. A., Filho, C. M. T. H., dos Reis, R., Reis, R. M., & Marques, M. M. C. (2021). A systematic review of microRNAs involved in cervical cancer progression. Cells, 10, 668. https://doi.org/10.3390/cells10030668
   PubMed Web of Science ®Google Scholar
• Chen, D., Enroth, S., Ivansson, E., & Gyllensten, U. (2014). Pathway analysis of cervical cancer genome-wide association study highlights the MHC region and pathways involved in response to infection. Human Molecular Genetics, 23 22, 6047–6060.
   PubMed Web of Science ®Google Scholar
• Chen, N., Szentirmay, M. N., Pawar, S. A., Sirito, M., Wang, J. C., Wang, Z., Zhai, Q., Yang, H., Peehl, D. M., Ware, J. L., & Sawadogo, M. (2006). Tumor-suppression function of transcription factor usf2 in prostate carcinogenesis. Oncogene, 25, 579–587.
   PubMed Web of Science ®Google Scholar
• Chen, A., Zhong, L., & Lv, J. (2019). Foxl1 overexpression is associated with poor outcome in patients with glioma. Oncology Letters, 18, 751–757.
   PubMed Web of Science ®Google Scholar
• Chi, T. F., Khoder-Agha, F., Mennerich, D., Kellokumpu, S., Miinalainen, I., Kietzmann, T., & Dimova, E. Y. (2020). Loss of usf2 promotes proliferation, migration and mitophagy in a redox-dependent manner. Redox Biology, 37, 101750. https://doi.org/10.1016/j.redox.2020.101750
   PubMed Web of Science ®Google Scholar
• Chin, C. H., Chen, S. H., Wu, H. H., Ho, C. W., Ko, M. T., & Lin, C. Y. (2014). cytoHubba: Identifying hub objects and sub-networks from complex interactome. BMC Systems Biology, 8(4), S11. https://doi.org/10.1186/1752-0509-8-S4-S11
   PubMedGoogle Scholar
• Choo, K. B., Huang, C. J., Chen, C. M., Han, C. P., & Au, L. C. (1995). Jun-b oncogene aberrations in cervical cancer cell lines. Cancer Letters, 93, 249–253.
   PubMed Web of Science ®Google Scholar
• Ciombor, K. K., & Bekaii-Saab, T. S. (2015). Selumetinib for the treatment of cancer. Expert Opinion on Investigational Drugs, 24, 111–123.
   PubMed Web of Science ®Google Scholar
• Daina, A., Michielin, O., & Zoete, V. (2017). Swissadme: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7, 42717.
   PubMed Web of Science ®Google Scholar
• den Boon, J. A., Pyeon, D., Wang, S. S., Horswill, M., Schiffman, M., Sherman, M., Zuna, R. E., Wang, Z., Hewitt, S. M., Pearson, R., Schott, M., Chung, L., He, Q., Lambert, P., Walker, J., Newton, M. A., Wentzensen, N., & Ahlquist, P. (2015). Molecular transitions from papillomavirus infection to cervical precancer and cancer: Role of stromal estrogen receptor signaling. Proceedings of the National Academy of Sciences of the United States of America, 112(25), E3255–E3264. https://doi.org/10.1073/pnas.1509322112
   PubMedGoogle Scholar
• Di Fiore, R., Suleiman, S., Drago-Ferrante, R., Subbannayya, Y., Pentimalli, F., Giordano, A., & Calleja-Agius, J. (2022). Cancer stem cells and their possible implications in cervical cancer: A short review. International Journal of Molecular Sciences, 23(9), 5167.
   PubMed Web of Science ®Google Scholar
• Dong, R. F., Zhuang, Y., Wang, Y., Yu Zhang, Z., Xu, X. Z., Rong Mao, Y., & Jin Yu, J. (2021). Tumor suppressor mir-192-5p targets trpm7 and inhibits proliferation and invasion in cervical cancer. The Kaohsiung Journal of Medical Sciences, 37, 699– 708.
   PubMed Web of Science ®Google Scholar
• Doorbar, J., Quint, W., Banks, L., Bravo, I. G., Stoler, M., Broker, T. R., & Stanley, M. A. (2012). The biology and life-cycle of human papillomaviruses. Vaccine, 30, F55–F70.
   PubMed Web of Science ®Google Scholar
• Eberhardt, J., Santos-Martins, D., Tillack, A. F., & Forli, S. (2021). Autodock vina 1.2.0: New docking methods, expanded force field, and python bindings. Journal of Chemical Information and Modeling, 61, 3891–3898. https://doi.org/10.1021/acs.jcim.1c00203
   PubMed Web of Science ®Google Scholar
• Fei Pei, Y., Yin, X., & Qiang Liu, X. (2018). Top2a induces malignant character of pancreatic cancer through activating β-catenin signaling pathway. Biochimica et Biophysica Acta. Molecular Basis of Disease, 1864, 197–207.
   PubMed Web of Science ®Google Scholar
• Fei, L., & Xu, H. (2018). Role of mcm2–7 protein phosphorylation in human cancer cells. Cell & Bioscience, 8, 43. https://doi.org/10.1186/s13578-018-0242-2
   PubMed Web of Science ®Google Scholar
• Filho, S. A., Nuovo, G. J., da Cunha, C. B., de Oliveira Ramos Pereira, L., Oliveira-Silva, M., Russomano, F. B., Pires, A., & Nicol, A. F. (2014). Correlation of mcm2 detection with stage and virology of cervical cancer. The International Journal of Biological Markers, 29, 363– 371.
   Web of Science ®Google Scholar
• Fornes, O., Castro-Mondragon, J. A., Khan, A., van der Lee, R., Zhang, X., Richmond, P. A., Modi, B. P., Correard, S., Gheorghe, M., Baranašić, D., Santana-Garcia, W., Tan, G., Chèneby, J., Ballester, B., Parcy, F., Sandelin, A., Lenhard, B., Wasserman, W. W., & Mathelier, A. (2020). JASPAR 2020: Update of the open-access database of transcription factor binding profiles. Nucleic Acids Research, 48(D1), D87–D92. https://doi.org/10.1093/nar/gkz1001
   PubMed Web of Science ®Google Scholar
• Gupta, S., & Gupta, M. K. (2017). Possible role of nanocarriers in drug delivery against cervical cancer. Nano Reviews & Experiments, 8(1), 1335567.
   PubMed Web of Science ®Google Scholar
• He, Z., Wang, X., Yang, Z., Jiang, Y., Li, L., Wang, X., Song, Z., Wang, X., Wan, J., Jiang, S., Zhang, N., & Cui, R. (2021). Expression and prognosis of cdc45 in cervical cancer based on the geo database. PeerJ, 9, e12114. https://doi.org/10.7717/peerj.12114
   PubMed Web of Science ®Google Scholar
• Henderson, Y. C., Chen, Y., Frederick, M. J., Lai, S. Y., & Clayman, G. L. (2010). Mek inhibitor pd0325901 significantly reduces the growth of papillary thyroid carcinoma cells in vitro and in vivo. Molecular Cancer Therapeutics, 9, 1968–1976.
   PubMed Web of Science ®Google Scholar
• Hu, X., Schwarz, J. K., Lewis, J. S., Huettner, P. C., Rader, J. S., Deasy, J. O., Grigsby, P. W., & Wang, X. (2010). A microRNA expression signature for cervical cancer prognosismicrorna signature in cervical cancer. Cancer Research, 70(4), 1441–1448.https://doi.org/10.1158/0008-5472.CAN-09-3289
   PubMed Web of Science ®Google Scholar
• Huang, L., Huang, Z., Fan, Y., He, L., Ye, M., Shi, K., Ji, B., Huang, J., Wang, Y., & Li, Q. (2017). Foxc1 promotes proliferation and epithelial-mesenchymal transition in cervical carcinoma through the pi3k-Akt signal pathway. American Journal of Translational Research, 93, 1297–1306.
   PubMed Web of Science ®Google Scholar
• Huseinovic, A., Jaspers, A., van Splunter, A. P., Sørgard, H., Wilting, S. M., Swarts, D. R. A., van der Meulen, I. H., van Beusechem, V. W., de Menezes, R. X., & Steenbergen, R. D. M. (2022). Functional screen for microRNAs suppressing anchorage-independent growth in human cervical cancer cells. International Journal of Molecular Sciences, 23, 4791. https://doi.org/10.3390/ijms23094791
   PubMed Web of Science ®Google Scholar
• Idris, S. F., Ahmad, S. S., Scott, M., Vassiliou, G. S., & Hadfield, J. (2013). The role of high-throughput technologies in clinical cancer genomics. Expert Review of Molecular Diagnostics, 13, 167–181.
   PubMed Web of Science ®Google Scholar
• Jhingran, A., Russell, A. H., Seiden, M. V., Duska, L. R., Goodman, A., Lee, S. L., Digumarthy, S. R., & Fuller, A. F. (2020). Cancers of the cervix, vulva, and vagina (pp. 1468–1507).
   Google Scholar
• Jia Ren, F., Yao, Y., Cai, X., & Ying Fang, G. (2021). Emerging role of mir-192-5p in human diseases. Frontiers in Pharmacology, 12, 614068. https://doi.org/10.3389/fphar.2021.614068
   PubMed Web of Science ®Google Scholar
• Jiao, X., Sherman, B. T., Huang, D. W., Stephens, R., Baseler, M. W., Lane, H. C., & Lempicki, R. A. (2020). DAVID-WS: A stateful web service to facilitate gene/protein list analysis. Bioinformatics (Oxford, England, 28(13), 1805–1806. https://pubmed.ncbi.nlm.nih.gov/22543366https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3381967/
   Google Scholar
• Kashyap, N., Krishnan, N., Kaur, S., & Ghai, S. (2019). Risk factors of cervical cancer: A case-control study. Asia-Pacific Journal of Oncology Nursing, 6(3), 308–314.
   PubMed Web of Science ®Google Scholar
• Kaur, G., Balasubramaniam, S. D., Lee, Y. J., Balakrishnan, V., & Oon, C. E. (2019). Minichromosome maintenance complex (mcm) genes profiling and mcm2 protein expression in cervical cancer development. Asian Pacific Journal of Cancer Prevention: APJCP, 20, 3043– 3049.
   PubMedGoogle Scholar
• Kim, S., Chen, J., Cheng, T., Gindulyte, A., He, J., He, S., Li, Q., Shoemaker, B. A., Thiessen, P. A., Yu, B., Zaslavsky, L., Zhang, J., & Bolton, E. E. (2018). PubChem 2019 update: Improved access to chemical data. Nucleic Acids Research, 47(D1), D1102–D1110. https://doi.org/10.1093/nar/gky1033
   Web of Science ®Google Scholar
• Kjær, S. K., Frederiksen, K., Munk, C., & Iftner, T. (2010). Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: Role of persistence. Journal of the National Cancer Institute, 102(19), 1478–1488.
   PubMedGoogle Scholar
• Kori, M., Gov, E., & Arga, K. Y. (2019). Novel genomic biomarker candidates for cervical cancer as identified by differential co-expression network analysis. Omics: A Journal of Integrative Biology, 235, 261–273.
   PubMed Web of Science ®Google Scholar
• Kuku, S., Proctor, I., Loddo, M., Kadalayil, L., KhoshZaban, M., Ledermann, J. A., & Mccormack, M. (2015). Do cell-cycle phase–specific markers predict disease grade, stage, and outcome in cervical carcinoma? International Journal of Gynecologic Cancer, 25, 1066–1072.
   PubMed Web of Science ®Google Scholar
• Kuleshov, M. V., Jones, M. R., Rouillard, A. D., Fernandez, N. F., Duan, Q., Wang, Z., Koplev, S., Jenkins, S. L., Jagodnik, K. M., Lachmann, A., McDermott, M. G., Monteiro, C. D., Gundersen, G. W., & Ma’ayan, A. 05 (2016). Enrichr: A comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Research, 44(W1), W90–W97. https://doi.org/10.1093/nar/gkw377
   PubMed Web of Science ®Google Scholar
• Kumer, A., Chakma, U., Chandro, A., Howlader, D., Akash, S., Kobir, M., Hossain, T., Matin, M. M., et al. (2022). Modified d-glucofuranose computationally screening for inhibitor of breast cancer and triple breast cancer: Chemical descriptor, molecular docking, molecular dynamics and qsar. Journal of the Chilean Chemical Society, 67(3), 5623–5635.
   Web of Science ®Google Scholar
• Kumer, A., Chakma, U., Matin, M. M., Akash, S., Chando, A., & Howlader, D. (2021). The computational screening of inhibitor for black fungus and white fungus by d-glucofuranose derivatives using in silico and SAR study. Organic Communications, 14(4), 305–322.
   Web of Science ®Google Scholar
• Kumer, A., Chakma, U., Rana, M. M., Chandro, A., Akash, S., Elseehy, M. M., Albogami, S., & El-Shehawi, A. M. (2022). Investigation of the new inhibitors by sulfadiazine and modified derivatives of α-d-glucopyranoside for white spot syndrome virus disease of shrimp by in silico: Quantum calculations, molecular docking, ADMET and molecular dynamics study. Molecules, 27(12), 3694.
   PubMed Web of Science ®Google Scholar
• Laengsri, V., Kerdpin, U., Plabplueng, C., Treeratanapiboon, L., & Nuchnoi, P. (2018). Cervical cancer markers: Epigenetics and micrornas. Laboratory Medicine, 49(2), 97–111.
   PubMed Web of Science ®Google Scholar
• Lee, J., Jeong, M. I., Kim, H.-R., Park, H., Moon, W.-K., & Kim, B. (2020). Plant extracts as possible agents for sequela of cancer therapies and cachexia. Antioxidants, 9(9), 836.
   Web of Science ®Google Scholar
• Lin, M., Ye, M., Zhou, J., Wang, Z. P., & Zhu, X. (2019). Recent advances on the molecular mechanism of cervical carcinogenesis based on systems biology technologies. Computational and Structural Biotechnology Journal, 17, 241–250.
   PubMed Web of Science ®Google Scholar
• Li, Y., Sun, C., Tan, Y., Li, L., Zhang, H., Liang, Y., Zeng, J., & Zou, H. mar (2020). Transcription levels and prognostic significance of the NFI family members in human cancers. PeerJ. 8, e8816–e8816. https://pubmed.ncbi.nlm.nih.gov/32219034https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7085295/
   PubMed Web of Science ®Google Scholar
• Li, X., Tian, R., Gao, H., Yan, F., Ying, L., Yang, Y., Yang, P., & Gao, Y. (2018). Identification of significant gene signatures and prognostic biomarkers for patients with cervical cancer by integrated bioinformatic methods. Technology in Cancer Research & Treatment, 17, 1533033818767455.
   Web of Science ®Google Scholar
• Liu, Y., Grimm, M., Tao Dai, W., Hou, M. J., Xiao, Z., & Cao, Y. (2019). Cb-dock: A web server for cavity detection-guided protein–ligand blind docking. Acta Pharmacologica Sinica, 41, 138– 144.
   PubMed Web of Science ®Google Scholar
• Liu, C. J., Hu, F. F., Xia, M. X., Han, L., Zhang, Q., & Guo, A. Y. (2018). GSCALite: A web server for gene set cancer analysis. Bioinformatics, 34(21), 3771–3772. https://doi.org/10.1093/bioinformatics/bty411
   PubMed Web of Science ®Google Scholar
• Liu, H., Xu, J., Yang, Y., Wang, X., Wu, E., Majerciak, V., Zhang, T., Steenbergen, R. D. M., Wang, H. K., Banerjee, N. S., Li, Y., Lu, W., Meyers, C., Zhu, J., Xie, X., Chow, L. T., & Zheng, Z.-M. (2021). Oncogenic HPV promotes the expression of the long noncoding RNA lnc-fanci-2 through e7 and yy1. Proceedings of the National Academy of Sciences, 118, e2014195118. https://doi.org/10.1073/pnas.2014195118
   Google Scholar
• Madhumati, G., Kavita, S. S., Anju, M., Uma, S., & Raj, M. H. (2012). Immunohistochemical expression of cell proliferating nuclear antigen (pcna) and p53 protein in cervical cancer. The Journal of Obstetrics and Gynecology of India, 62, 557–561.
   Google Scholar
• Mailand, N., Gibbs-Seymour, I., & Bekker-Jensen, S. (2013). Regulation of pcna–protein interactions for genome stability. Nature Reviews Molecular Cell Biology, 14, 269–282.
   PubMed Web of Science ®Google Scholar
• Marth, C., Landoni, F., Mahner, S., McCormack, M., Gonzalez-Martin, A., & Colombo, N. (2017). Cervical cancer: Esmo clinical practice guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 28, iv72–iv83.
   PubMed Web of Science ®Google Scholar
• Medina-Martinez, I., Barron, V., Roman-Bassaure, ’. E., Juarez’-Torres, E., Guardado-Estrada, M., Espinosa, A. M., Bermudez, M., Fernandez, F., Venegas-Vega, C., Orozco, L., Zenteno, E., Kofman, S., & Berumen, J. (2014). Impact of gene dosage on gene expression, biological processes and survival in cervical cancer: A genome-wide follow-up study. PLoS One, 9, 1–23. https://doi.org/10.1371/journal.pone.0097842
   Web of Science ®Google Scholar
• Menzin, A. W., King, S. A., Aikins, J. K., Mikuta, J. J., & Rubin, S. C. (1994). Taxol (paclitaxel) was approved by FDA for the treatment of patients with recurrent ovarian cancer. Gynecologic Oncology, 54, 103.
   PubMedGoogle Scholar
• Montgomery, M. P., Dune, T., Shetty, P. K., & Shetty, A. K. (2015). Knowledge and acceptability of human papillomavirus vaccination and cervical cancer screening among women in Karnataka, India. Journal of Cancer Education, 30(1), 130–137.
   PubMed Web of Science ®Google Scholar
• Nahand, J. S., Vandchali, N. R., Darabi, H., Doroudian, M., Banafshe, H. R., Moghoofei, M., Babaei, F., Salmaninejad, A., & Mirzaei, H. (2020). Exosomal microRNAs: Novel players in cervical cancer. Epigenomics, 12, 1651–1660. https://doi.org/10.2217/epi-2020-0026
   PubMed Web of Science ®Google Scholar
• Nguyen, N. N. Y., Choi, T. G., Kim, J., Jung, M. H., Ko, S. H., Shin, Y., Kang, I., Ha, J., Kim, S. S., & Jo, Y. H. (2020). A 70-gene signature for predicting treatment outcome in advanced-stage cervical cancer. Molecular Therapy-Oncolytics, 19, 47–56.
   PubMed Web of Science ®Google Scholar
• Nirala, N. K., Li, Q., Ghule, P. N., Chen, H.-J., Li, R., Zhu, L. J., Wang, R., Rice, N. P., Mao, J.-H., Stein, J. L., Stein, G. S., van Wijnen, A. J., & Ip, Y. T. (2021). Hinfp is a guardian of the somatic genome by repressing transposable elements. Proceedings of the National Academy of Sciences, 118, e2100839118. https://doi.org/10.1073/pnas.2100839118
   Google Scholar
• Pedroza-Torres, A., Lopez’-Urrutia, E., Garc’ıa-Castillo, V., Jacobo-Herrera, N., Herrera, L. A., Peralta-Zaragoza, O., Lopez’-Camarillo, C., De Leon, D. C., Fernandez’-Retana, J., Cerna-Cortes’, J. F., et al. (2014). MicroRNAs in cervical cancer: Evidences for a miRNA profile deregulated by HPV and its impact on radio-resistance. Molecules, 19(5), 6263–6281.
   PubMed Web of Science ®Google Scholar
• Petojevic, T., Pesavento, J. J., Costa, A., Liang, J., Wang, Z., Berger, J. M., & Botchan, M. R. (2015). Cdc45 (cell division cycle protein 45) guards the gate of the eukaryote replisome helicase stabilizing leading strand engagement. Proceedings of the National Academy of Sciences, 112, E249–E258.
   Google Scholar
• Plummer, M., Herrero, R., Franceschi, S., Meijer, C. J., Snijders, P., Bosch, F. X., de Sanjose, S., & Munoz, N. (2003). Smoking and cervical cancer: Pooled analysis of the iarc multi-centric case–control study. Cancer Causes & Control, 14(9), 805–814. ’ ˜
   PubMed Web of Science ®Google Scholar
• Reddy, K. B. (2015). Microrna (mirna) in cancer. Cancer Cell International, 15(1), 1–6.
   PubMedGoogle Scholar
• Rouillard, A. D., Gundersen, G. W., Fernandez, N. F., Wang, Z., Monteiro, C. D., McDermott, M. G., & Ma’ayan, A. (2016). The harmonizome: A collection of processed datasets gathered to serve and mine knowledge about genes and proteins. Database., 2016.
   Google Scholar
• Rung, J., & Brazma, A. (2013). Reuse of public genome-wide gene expression data. Nature Reviews Genetics, 14(2), 89–99.
   PubMed Web of Science ®Google Scholar
• Sabapathi, N., Sabarimurugan, S., Royam, M. M., Kumarasamy, C., Xu, X., Xu, G., & Jayaraj, R. (2019). Prognostic significance of foxc1 in various cancers: A systematic review and meta-analysis. Molecular Diagnosis & Therapy, 23, 695–706.
   PubMed Web of Science ®Google Scholar
• Santos, A., Tsafou, K., Stolte, C., Pletscher-Frankild, S., O’Donoghue, S. I., & Jensen, L. J. (2015). Comprehensive comparison of large-scale tissue expression datasets. PeerJ, 3, e1054. https://doi.org/10.7717/peerj.1054
   PubMed Web of Science ®Google Scholar
• Sastry, G. M., Adzhigirey, M., Day, T., Annabhimoju, R., & Sherman, W. (March 2013). Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments. Journal of Computer-Aided Molecular Design, 27(3), 221–234. https://doi.org/10.1007/s10822-013-9644-8
   PubMed Web of Science ®Google Scholar
• Serrat′ı, S., De Summa, S., Pilato, B., Petriella, D., Lacalamita, R., Tommasi, S., & Pinto, R. (2016). Next-generation sequencing: advances and applications in cancer diagnosis. Onco Targets and Therapy, 9, 7355.
   PubMed Web of Science ®Google Scholar
• Sethupathy, P., Corda, B., & Hatzigeorgiou, A. G. (2006). TarBase: A comprehensive database of experimentally supported animal microRNA targets. RNA, 12, 192–197. https://pubmed.ncbi.nlm.nih.gov/16373484https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1370898/
   Google Scholar
• Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003). Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Research, 13(11), 2498–2504.
   PubMed Web of Science ®Google Scholar
• Song, Z., Cui, Y., Li, Q., Deng, J., Ding, X., He, J., Liu, Y., Ju, Z., & Fang, L. (2021). The genetic variability, phylogeny and functional significance of e6, e7 and lcr in human papillomavirus type 52 isolates in Sichuan, China. Virology Journal, 18, 94. https://doi.org/10.1186/s12985-021-01565-5
   PubMed Web of Science ®Google Scholar
• Sun, J., Shi, R., Zhao, S., Li, X., Lu, S., Bu, H., & Ma, X. (2017). Cell division cycle 45 promotes papillary thyroid cancer progression via regulating cell cycle. Tumor Biology, 39, 1010428317705342. https://doi.org/10.1177/1010428317705342
   Google Scholar
• Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a Cancer Journal for Clinicians, 71(3), 209–249.
   PubMed Web of Science ®Google Scholar
• Szklarczyk, D., Gable, A. L., Lyon, D., Junge, A., Wyder, S., Huerta-Cepas, J., Simonovic, M., Doncheva, N. T., Morris, J. H., Bork, P., Jensen, L. J., & von Mering, C. (2019) STRING v11: Protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Research, 47(D1), D607–D613. https://doi.org/10.1093/nar/gky1131
   PubMed Web of Science ®Google Scholar
• Tang, Z., Kang, B., Li, C., Chen, T., & Zhang, Z. 05 (2019). GEPIA2: An enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Research, 47(W1), W556–W560. https://doi.org/10.1093/nar/gkz430
   PubMed Web of Science ®Google Scholar
• The Cancer Genome Atlas Research Network. (2017). Integrated genomic and molecular characterization of cervical cancer. Nature, 543(7645), 378.
   PubMed Web of Science ®Google Scholar
• Tilborghs, S., Corthouts, J., Verhoeven, Y., Arias, D., Rolfo, C. D., Trinh, X. B., & van Dam, P. A. (2017). The role of nuclear factor-kappa b signaling in human cervical cancer. Critical Reviews in Oncology/Hematology, 120, 141–150.
   PubMed Web of Science ®Google Scholar
• Wang, J. C. (2002). Cellular roles of DNA topoisomerases: A molecular perspective. Nature Reviews Molecular Cell Biology, 3, 430–440.
   PubMed Web of Science ®Google Scholar
• Wang, B., Shen, Y., Zou, Y., Qi, Z., Huang, G.-L., Xia, S., Gao, R., Hu Li, F., & Huang, Z. (2020). Top2a promotes cell migration, invasion and epithelial–mesenchymal transition in cervical cancer via activating the pi3k/Akt signaling. Cancer Management and Research, 12, 3807–3814.
   PubMed Web of Science ®Google Scholar
• Wang, W., Yue, Z., Tian, Z., Xie, Y., Zhang, J., She, Y., Yang, B.-Y., Ye, Y., & Yang, Y. (2018). Expression of yin yang 1 in cervical cancer and its correlation with e-cadherin expression and hpv16 e6. PLoS One, 13, e0193340. https://doi.org/10.1371/journal.pone.0193340
   PubMed Web of Science ®Google Scholar
• Wang, P., Zhang, L., Zhang, J., & Xu, G. (2022). Microrna-124-3p inhibits cell growth and metastasis in cervical cancer by targeting igf2bp1. Experimental and Therapeutic Medicine, 23. https://doi.org/10.3892/etm.2022.11157
   Web of Science ®Google Scholar
• Wei, L., Chen, J., Song, C., Zhang, Y., Zhang, Y., Xu, M., Feng, C., Gao, Y., Qian, F., Wang, Q., Shang, D., Zhou, X., Zhu, J., Wang, X., Jia, Y., Liu, J., Zhu, Y.-B., & Li, C. (2021). Cancer CRC: A comprehensive cancer core transcriptional regulatory circuit resource and analysis platform. Frontiers in Oncology, 11, 761700. https://doi.org/10.3389/fonc.2021.761700
   PubMed Web of Science ®Google Scholar
• Xie, B., Ding, Q., Han, H., & Wu, D. (2013). Mircancer: A microRNA-cancer association database constructed by text mining on literature. Bioinformatics, 295, 638–644.
   PubMed Web of Science ®Google Scholar
• Yang, Z., Ren, F., Liu, C., He, S., Sun, G., Gao, Q., Yao, L., Zhang, Y., Miao, R., Cao, Y., Zhao, Y., Zhong, Y., & Zhao, H. (2010). dbdemc: A database of differentially expressed miRNAs in human cancers. BMC Genomics, 11, S5–S5.
   PubMed Web of Science ®Google Scholar
• Yang, C., Zhang, Z.-C., Liu, T., Xu, Y., Xia, B., & Lou, G. (2020). E2f1/2/7/8 as independent indicators of survival in patients with cervical squamous cell carcinoma. Cancer Cell International, 20, 1–17. https://doi.org/10.1186/s12935-020-01594-0
   PubMed Web of Science ®Google Scholar
• Yu Qin, Y., Gong, W., di Zhang, M., Dong Wang, J., Tang, Z., & Quan, Z. (2014). Forkhead box l1 is frequently downregulated in gallbladder cancer and inhibits cell growth through apoptosis induction by mitochondrial dysfunction. PLoS One, 9, e102084. https://doi.org/10.1371/journal.pone.0102084
   PubMed Web of Science ®Google Scholar
• Yu, B., Chen, L., Zhang, W., Li, Y., Zhang, Y., Gao, Y., Teng, X., Zou, L., Wang, Q., Jia, H., Liu, X., Zheng, H., Hou, P.-F., Yang Yu, H., Sun, Y., Zhang, Z., Zhang, P., & Zhang, L. (2020). Top2a and cenpf are synergistic master regulators activated in cervical cancer. BMC Medical Genomics, 13, 145.
   PubMed Web of Science ®Google Scholar
• Zhai, Y., Kuick, R., Nan, B., Ota, I., Weiss, S. J., Trimble, C. L., Fearon, E. R., & Cho, K. R. (2007). Gene expression analysis of preinvasive and invasive cervical squamous cell carcinomas identifies HOXC10 as a key mediator of invasion. Cancer Research, 67(21), 10163–10172.
   PubMed Web of Science ®Google Scholar
• Zhao, M., Huang, W., Zou, S., Shen, Q., & Zhu, X. (2020). A five-genes-based prognostic signature for cervical cancer overall survival prediction. International Journal of Genomics, 2020.
   Web of Science ®Google Scholar
• Zheng, X., Liu, Z., Zhong, J.-X., Zhou, L., Chen, J., Zheng, L., Li, Z., Zhang, R., Pan, J., Wu, Y., Wei Liu, Z., & Kang, T. (2022). Downregulation of hinfp induces senescence-associated secretory phenotype to promote metastasis in a non-cell-autonomous manner in bladder cancer. Oncogene, 41, 3587–3598.
   PubMed Web of Science ®Google Scholar
• Zhou, G., Soufan, O., Ewald, J., Hancock, R. E. W., Basu, N., & Xia, J. (2019). NetworkAnalyst 3.0: A visual analytics platform for comprehensive gene expression profiling and meta-analysis. Nucleic Acids Research, 47(W1), W234–W241. https://doi.org/10.1093/nar/gkz240
   PubMed Web of Science ®Google Scholar
• Zhou, B., Qie, M., Wang, Y., Yan, L., Zhang, Z., Liang, A., Wang, T. C., Wang, X., Song, Y., & Zhang, L. (2010). Relationship between nfkb1 -94 insertion/deletion attg polymorphism and susceptibility of cervical squamous cell carcinoma risk. Annals of Oncology: Official Journal of the European Society for Medical Oncology, 213, 506–511.
   PubMed Web of Science ®Google Scholar
• Zou, S. H., Du, X. R., Lin, H., Wang, P. C., & Li, M. (2018). Paclitaxel inhibits the progression of cervical cancer by inhibiting autophagy via lncrnarp11-381n20.2. European Review for Medical and Pharmacological Sciences, 22, 3010–3017.
   PubMed Web of Science ®Google Scholar
• Zuberi, Z., Mremi, A., Chilongola, J. O., Semango, G., & Sauli, E. (2021). Expression analysis of p16 and top2a protein biomarkers in cervical cancer lesions and their correlation with clinico-histopathological characteristics in a referral hospital, Tanzania. PLoS One, 16, e0259096.https://doi.org/10.1371/journal.pone.0259096
   PubMed Web of Science ®Google Scholar